These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25300953)

  • 1. Effect of compounds affecting ABCA1 expression and CETP activity on the HDL pathway involved in intestinal absorption of lutein and zeaxanthin.
    Niesor EJ; Chaput E; Mary JL; Staempfli A; Topp A; Stauffer A; Wang H; Durrwell A
    Lipids; 2014 Dec; 49(12):1233-43. PubMed ID: 25300953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.
    Wang SP; Daniels E; Chen Y; Castro-Perez J; Zhou H; Akinsanya KO; Previs SF; Roddy TP; Johns DG
    J Lipid Res; 2013 Oct; 54(10):2858-65. PubMed ID: 23898048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter.
    Connor WE; Duell PB; Kean R; Wang Y
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4226-31. PubMed ID: 17724211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anacetrapib and dalcetrapib differentially alters HDL metabolism and macrophage-to-feces reverse cholesterol transport at similar levels of CETP inhibition in hamsters.
    Briand F; Thieblemont Q; Muzotte E; Burr N; Urbain I; Sulpice T; Johns DG
    Eur J Pharmacol; 2014 Oct; 740():135-43. PubMed ID: 25008069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
    Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
    Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETP.
    Maugeais C; Perez A; von der Mark E; Magg C; Pflieger P; Niesor EJ
    Biochim Biophys Acta; 2013 Nov; 1831(11):1644-50. PubMed ID: 23872476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of low HDL-C subjects with the CETP modulator dalcetrapib increases plasma campesterol only in those without ABCA1 and/or ApoA1 mutations.
    Niesor EJ; Kallend D; Bentley D; Kastelein JJ; Kees Hovingh G; Stroes ES
    Lipids; 2014 Dec; 49(12):1245-9. PubMed ID: 25281277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport.
    Niesor EJ; Magg C; Ogawa N; Okamoto H; von der Mark E; Matile H; Schmid G; Clerc RG; Chaput E; Blum-Kaelin D; Huber W; Thoma R; Pflieger P; Kakutani M; Takahashi D; Dernick G; Maugeais C
    J Lipid Res; 2010 Dec; 51(12):3443-54. PubMed ID: 20861162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism.
    Niesor EJ
    Curr Opin Lipidol; 2011 Aug; 22(4):288-95. PubMed ID: 21587074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.
    Yamashita S; Ruscica M; Macchi C; Corsini A; Matsuzawa Y; Sirtori CR
    Atherosclerosis; 2018 Nov; 278():286-298. PubMed ID: 30347344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins.
    Thomas SE; Harrison EH
    J Lipid Res; 2016 Oct; 57(10):1865-1878. PubMed ID: 27538825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys.
    Brodeur MR; Rhainds D; Charpentier D; Mihalache-Avram T; Mecteau M; Brand G; Chaput E; Perez A; Niesor EJ; Rhéaume E; Maugeais C; Tardif JC
    J Lipid Res; 2017 Jul; 58(7):1282-1291. PubMed ID: 28515138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: in vitro vs in vivo comparison using anacetrapib and dalcetrapib.
    Johns DG; Chen Y; Wang SP; Castro-Perez J; Previs SF; Roddy TP
    Eur J Pharmacol; 2015 Sep; 762():256-62. PubMed ID: 26049012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.
    Tchoua U; D'Souza W; Mukhamedova N; Blum D; Niesor E; Mizrahi J; Maugeais C; Sviridov D
    Cardiovasc Res; 2008 Mar; 77(4):732-9. PubMed ID: 18056760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
    Ray KK; Ditmarsch M; Kallend D; Niesor EJ; Suchankova G; Upmanyu R; Anzures-Cabrera J; Lehnert V; Pauly-Evers M; Holme I; Štásek J; van Hessen MW; Jones P;
    Eur Heart J; 2014 Jul; 35(27):1792-800. PubMed ID: 24639426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E secretion by Caco-2 monolayers to APOA1, but not to HDL, is vitamer selective.
    Nicod N; Parker RS
    J Nutr; 2013 Oct; 143(10):1565-72. PubMed ID: 23946344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
    Murthy S; Born E; Mathur SN; Field FJ
    J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.
    Mohammadpour AH; Akhlaghi F
    Clin Pharmacokinet; 2013 Aug; 52(8):615-26. PubMed ID: 23658137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.